Grover Theresa R, Murthy Karna, Brozanski Beverly, Gien Jason, Rintoul Natalie, Keene Sarah, Najaf Tasnim, Chicoine Louis, Porta Nicolas, Zaniletti Isabella, Pallotto Eugenia K
Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colorado.
Ann and Robert H. Lurie Children's Hospital and Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Am J Perinatol. 2015 Sep;32(11):1038-44. doi: 10.1055/s-0035-1548729. Epub 2015 Mar 31.
The aim of this study is to characterize medical and surgical therapies and short-term outcomes in infants with congenital diaphragmatic hernia (CDH).
Retrospective analysis of CDH infants admitted to 27 children's hospitals submitting data to Children's Hospital Neonatal Database (CHND) from 2010 to 2013, stratified by gestational age, birth weight, and survival.
A total of 572 infants were identified, 508 (89%) born ≥ 34 weeks' gestation and ≥ 2 kg. More mature infants had higher APGAR scores, shorter duration of mechanical ventilation, and were more likely to receive extracorporeal membrane oxygenation (ECMO). Overall, mortality for the cohort was 29%, with mortality lower in infants born ≥ 34 weeks' gestation and ≥ 2 kg (26 vs. 50%, p < 0.01). Nonsurvivors were more likely to receive treatment with high-frequency oscillatory ventilation (HFOV), vasopressors, pulmonary vasodilators, and ECMO, and to have associated major congenital anomalies than survivors. In hospital morbidity and complications were relatively uncommon among survivors.
Infants with CDH have a high risk of morbidity and mortality, and for preterm infants with CDH those risks are amplified. Patterns of respiratory and circulatory support appeared to be different for survivors. In addition to established data registries, this consortium of regional neonatal intensive care units provides a new collaborative effort to describe short-term outcomes for infants referred with CDH.
本研究旨在描述先天性膈疝(CDH)患儿的内科及外科治疗方法和短期预后情况。
对2010年至2013年向儿童医院新生儿数据库(CHND)提交数据的27家儿童医院收治的CDH患儿进行回顾性分析,按胎龄、出生体重和生存情况进行分层。
共纳入572例患儿,其中508例(89%)胎龄≥34周且出生体重≥2千克。胎龄较大的患儿阿氏评分更高,机械通气时间更短,且更有可能接受体外膜肺氧合(ECMO)治疗。总体而言,该队列的死亡率为29%,胎龄≥34周且出生体重≥2千克的患儿死亡率较低(26%对50%,P<0.01)。与存活患儿相比,死亡患儿更有可能接受高频振荡通气(HFOV)、血管活性药物、肺血管扩张剂和ECMO治疗,且合并主要先天性畸形的可能性更大。存活患儿的院内发病率和并发症相对较少。
CDH患儿有较高的发病和死亡风险,对于早产CDH患儿,这些风险会进一步增加。存活患儿的呼吸和循环支持模式似乎有所不同。除了现有的数据登记系统外,这个区域新生儿重症监护病房联盟为描述转诊的CDH患儿的短期预后提供了一项新的合作努力。